Optimizing Hereditary Cancer Risk Assessment and Genetic Testing Workflow in Interprofessional Women's Health Practice: A Multicenter Survey of Advanced Practice Providers
Journal of Midwifery & Women's Health · 2026
DOI: 10.1111/jmwh.70134 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Midwifery & Women's Health, 2026. Verfasst von Elaine Mielcarski und 7 weiteren Autor:innen. Beteiligte Einrichtung: Associates for Women's Medicine, North Syracuse, New York. Hauptthemen laut MEDLINE: Genetic Testing, Workflow, Nurse Practitioners, Women's Health Services. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Myriad Genetics.
Abstract (Originalsprache)
Introduction
Advanced practice providers (APPs), including certified nurse‐midwives (CNMs)/certified midwives and nurse practitioners, are well positioned to meet the growing demand for women's health care services. In interprofessional obstetric and gynecologic settings, APPs’ scope of practice includes performing hereditary cancer risk assessments (HCRAs) and genetic evaluations, comparable with physicians. However, time constraints, limited confidence, and inadequate resources may hinder APPs’ ability to routinely and effectively incorporate HCRA and genetic testing into practice. Process This prospective, single‐arm health care quality improvement initiative introduced workflow innovations and tools to improve HCRA workflow. This intervention included training on using online family history screening and virtual patient education tools within a standardized HCRA. Metrics related to genetic evaluation and testing completion and the experiences of women and APP respondents were recorded preintervention and postintervention. Data were analyzed using descriptive statistics and univariate conditional logistic regression models. Outcomes Following workflow standardization, APPs noted increases of 27.1 percentage points in the proportion of women offered genetic testing and 26.4 percentage points in the genetic testing completion rate (26.4%). APPs agreed or strongly agreed that the workflow modification improved their confidence in performing HCRA (91.7%) and meeting the standard of care (91.7%) and supported guideline adherence (83.3%) and ease of practice integration (66.7%).
Discussion
APPs care for women with similar risk profiles as physicians and are equally capable of implementing novel tools and processes to provide evidence‐based, personalized HCRA consistent with their scope of practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Associates for Women's Medicine, North Syracuse, New York.
- Myriad Genetics, Salt Lake City, Utah.
Förderung
- Myriad Genetics
Zitieren
APA
Mielcarski, E., Karanik, D., Bagley, H., Smith, E., Steele, A., Schneider, L., Lenz, L., & Adkins, R. T. (2026). Optimizing Hereditary Cancer Risk Assessment and Genetic Testing Workflow in Interprofessional Women's Health Practice: A Multicenter Survey of Advanced Practice Providers. Journal of Midwifery & Women's Health. https://doi.org/10.1111/jmwh.70134
Vancouver
Mielcarski E, Karanik D, Bagley H, Smith E, Steele A, Schneider L, et al. Optimizing Hereditary Cancer Risk Assessment and Genetic Testing Workflow in Interprofessional Women's Health Practice: A Multicenter Survey of Advanced Practice Providers. Journal of Midwifery & Women's Health. 2026. doi:10.1111/jmwh.70134
BibTeX
@article{Mielcarski2026,
author = {Mielcarski, Elaine and Karanik, Dana and Bagley, Heather and Smith, Edith and Steele, Amanda and Schneider, Logan and Lenz, Lauren and Adkins, Royce T},
title = {Optimizing Hereditary Cancer Risk Assessment and Genetic Testing Workflow in Interprofessional Women's Health Practice: A Multicenter Survey of Advanced Practice Providers},
journal = {Journal of Midwifery & Women's Health},
year = {2026},
doi = {10.1111/jmwh.70134}
}
EUVIMED